Nexalin Technology (NXL) Fundamentals 2026 — Revenue Analysis | SniperIQ
Nexalin Technology (NXL) is a US-listed Healthcare company in Medical - Devices with a market capitalization of
01,647 in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Nexalin Technology's market cap?
Nexalin Technology (NXL) has a market capitalization of approximately
What is Nexalin Technology's P/E ratio?
Nexalin Technology's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 3.2x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Nexalin Technology?
Nexalin Technology runs a net profit margin of -3022.9%, a gross margin of -102.9%, and an operating margin of -3084.2%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Nexalin Technology generate?
Nexalin Technology reported revenue of
Does Nexalin Technology pay a dividend?
Nexalin Technology does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Nexalin Technology financially healthy?
Nexalin Technology carries a debt-to-equity ratio of 0.00x and a current ratio of 4.07x, with a market beta of 4.03. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Nexalin Technology a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Nexalin Technology (NXL) the key facts are: market cap
01,647, 52-week range 0.305-2. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.Track Nexalin Technology's full fundamentals live
Get Nexalin Technology's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.